Table 4 Association parameters of rules based on the patient history and the administered drugs (sort by lift)

[1]

{benzodiazepines, dementia}

=>

{fall-related AEs}

[2]

{benzodiazepines, herpes zoster}

=>

{fall-related AEs}

[3]

{calcium channel blockers, benign prostate hypertrophy}

=>

{fall-related AEs}

[4]

{opioids, back pain}

=>

{fall-related AEs}

[5]

{calcium channel blockers, herpes zoster}

=>

{fall-related AEs}

[6]

{opioids, SSRI}

=>

{fall-related AEs}

[7]

{benzodiazepines, insomnia}

=>

{fall-related AEs}

[8]

{calcium channel blockers, dementia Alzheimer’s type}

=>

{fall-related AEs}

[9]

{dementia Alzheimer’s type, benzodiazepines}

=>

{fall-related AEs}

[10]

{SSRI, depression, benzodiazepines}

=>

{fall-related AEs}

[11]

{calcium channel blockers, SSRI, benzodiazepines}

=>

{fall-related AEs}

[12]

{type 2 diabetis mellitus, benzodiazepines}

=>

{fall-related AEs}

[13]

{SSRI, depression}

=>

{fall-related AEs}

[14]

{SSRI, non-selective monoamine reuptake inhibitors}

=>

{fall-related AEs}

[15]

{benzodiazepines, hypertension}

=>

{fall-related AEs}

[16]

{opioids, pain}

=>

{fall-related AEs}

[17]

{SSRI, benzodiazepines, non-selective monoamine reuptake inhibitors}

=>

{fall-related AEs}

[18]

{depression, benzodiazepines}

=>

{fall-related AEs}

[19]

{SSRI}

=>

{fall-related AEs}

[20]

{calcium channel blockers, benzodiazepines, α-blockers}

=>

{fall-related AEs}

[21]

{calcium channel blockers, SSRI}

=>

{fall-related AEs}

[22]

{SSRI, benzodiazepines}

=>

{fall-related AEs}

[23]

{calcium channel blockers, osteoporosis}

=>

{fall-related AEs}

[24]

{non-selective monoamine reuptake inhibitors}

=>

{fall-related AEs}

[25]

{hypertension, α-blockers}

=>

{fall-related AEs}

[26]

{benzodiazepines, diabetis mellitus}

=>

{fall-related AEs}

[27]

{benzodiazepines, α-blockers}

=>

{fall-related AEs}

[28]

{benzodiazepines, hypnotics and sedatives}

=>

{fall-related AEs}

[29]

{calcium channel blockers, benzodiazepines, hypertension}

=>

{fall-related AEs}

[30]

{calcium channel blockers, hypertension}

=>

{fall-related AEs}

[31]

{benzodiazepines, schizophrenia}

=>

{fall-related AEs}

[32]

{calcium channel blockers, chronic hepatitis C}

=>

{fall-related AEs}

[33]

{benzodiazepines}

=>

{fall-related AEs}

[34]

{calcium channel blockers, benzodiazepine}

=>

{fall-related AEs}

[35]

{α-blockers}

=>

{fall-related AEs}

[36]

{type 2 diabetis mellitus, calcium channel blockers}

=>

{fall-related AEs}

[37]

{benzodiazepines, non-selective monoamine reuptake inhibitors}

=>

{fall-related AEs}

[38]

{calcium channel blockers, α-blockers}

=>

{fall-related AEs}

[39]

{hypnotics and sedatives}

=>

{fall-related AEs}

[40]

{calcium channel blockers, diabetis mellitus}

=>

{fall-related AEs}

[41]

{benzodiazepines, chronic hepatitis C}

=>

{fall-related AEs}

[42]

{benzodiazepines, rheumatoid arthritis}

=>

{fall-related AEs}

[43]

{calcium channel blockers}

=>

{fall-related AEs}

[44]

{diuretics, hypertension}

=>

{fall-related AEs}

[45]

{benzodiazepines, diuretics}

=>

{fall-related AEs}